The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Open accessAbstract
Background: Primary aldosteronism (PA), a primary adrenal disorder leading to excessive aldosterone production by one or both adrenal glands, is a common cause of hypertension. It is associated with an increased risk of cardiovascular complications compared with primary hypertension. Despite effective methods for diagnosing and treating PA, it remains markedly underdiagnosed and undertreated. Objective: To develop an updated guideline that provides a practical, clinical approach to identifying and managing PA to improve diagnosis rates and encourage targeted treatment. Methods: The Guideline Development Panel (GDP), composed of a multidisciplinary panel of clinical experts and experts in systemic review methodology, used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach to define 10 questions related to the diagnosis and treatment of PA. Systematic reviews were conducted for each question. The GDP used the GRADE Evidence to Decision (EtD) framework to consider contextual factors, such as stakeholder values and preferences, costs and required resources, cost-effectiveness, acceptability, feasibility, and the potential impact on health equity. Results: We suggest that all individuals with hypertension be screened for PA by measuring aldosterone and renin and determining the aldosterone to renin ratio, and that subsequent clinical care be guided by the results. We suggest that individuals with PA receive PA-specific therapy, either medical or surgical. In individuals who screen positive for PA, we suggest (1) commencement of PA-specific medical therapy in individuals who do not desire or are not candidates for surgery and in situations where the probability of lateralizing PA (excess aldosterone produced by one adrenal) is low based on screening results; and (2) aldosterone suppression testing in situations when screening results indicate an intermediate probability for lateralizing PA and individualized decision making confirms a desire to pursue eligibility for surgical therapy. In those who test positive by aldosterone suppression testing, and in those in whom screening results show a high probability of lateralizing PA (obviating the need for aldosterone suppression testing), we suggest adrenal lateralization with computed tomography scanning and adrenal venous sampling prior to deciding the treatment approach (medical vs surgical). In all individuals with PA and an adrenal adenoma, we suggest performing a 1-mg overnight dexamethasone suppression test. We suggest the use of mineralocorticoid receptor antagonists (MRAs) over epithelial sodium-channel (ENaC) inhibitors in the medical treatment of PA. We suggest the use of spironolactone over other MRAs, given its lower cost and greater availability; however, all MRAs, when titrated to equivalent potencies, are anticipated to have similar efficacy in treating PA. Thus, MRAs with greater mineralocorticoid receptor specificity and fewer androgen/progesterone receptor-mediated side effects may be preferred in some situations. In individuals receiving MRA therapy, we suggest monitoring renin and, in those whose hypertension remains uncontrolled and renin is suppressed, titrating the MRA to increase renin. Conclusion: These recommendations provide a practical framework for the diagnosis and treatment of PA. They are based on currently available literature and take into consideration outcomes that are important to key stakeholders. The goal is to increase identification of individuals with PA and, by initiating PA-specific medical or surgical therapy, improve blood pressure control and reduce PA-associated adverse cardiovascular events. The guidelines also highlight important knowledge gaps in PA diagnosis and management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
Bakris, G. L., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, P., Kolkhof, P., Nowack, C., Schloemer, P., Joseph, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2025845 · Cited by 2,935
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Self-citationThe diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Self-citationCardiovascular events with finerenone in kidney disease and type 2 diabetes
Pitt, B., Filippatos, G., Agarwal, R., Anker, S. D., Bakris, G. L., Rossing, P., Joseph, A., Kolkhof, P., Nowack, C., Schloemer, P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110956 · Cited by 1,814
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K., Meerpohl, J. J., Coello, P. A., Rind, D., Montori, V. M., Brito, J. P., Norris, S., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,315
Self-citationWilliams, B., MacDonald, T. M., Morant, S., Webb, D. J., Sever, P., McInnes, G., Ford, I., Cruickshank, J. K., Caulfield, M. J., Salsbury, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00257-3 · Cited by 1,308
Monticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072
Self-citation[Principles and practice of mass screening for disease].
Wilson, J. M., & Jungner, Y. G. (1968) · PubMed · Cited by 1,008
Williams, T. A., Lenders, J. W. M., Mulatero, P., Burrello, J., Rottenkolber, M., Adolf, C., Satoh, F., Amar, L., Quinkler, M., Deinum, J., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30135-3 · Cited by 969
Self-citationMulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Solomon, S. D., McMurray, J. J. V., Vaduganathan, M., Claggett, B., Jhund, P. S., Desai, A. S., Henderson, A. D., Lam, C. S. P., Pitt, B., Senni, M., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2407107 · Cited by 893
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice
Monticone, S., Burrello, J., Tizzani, D., Bertello, C., Viola, A., Buffolo, F., Gabetti, L., Mengozzi, G., Williams, T. A., Rabbia, F., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.052 · Cited by 882
Self-citationSchünemann, H. J., Cushman, M., Burnett, A. E., Kahn, S. R., Beyer-Westendorf, J., Spencer, F. A., Rezende, S. M., Zakai, N. A., Bauer, K. A., Dentali, F., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018022954 · Cited by 819
Fassnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J., Pelsma, I., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 786
Role for adrenal venous sampling in primary aldosteronism
Young, W. F., Stanson, A. W., Thompson, G. B., Grant, C. S., Farley, D. R., & van Heerden, J. A. (2004) · Surgery · doi:10.1016/j.surg.2004.06.051 · Cited by 735
Self-citationHundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M., & Vaidya, A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30367-4 · Cited by 677
Self-citationThe Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study
Brown, J. M., Siddiqui, M., Calhoun, D. A., Carey, R. M., Hopkins, P. N., Williams, G. H., & Vaidya, A. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0065 · Cited by 649
Self-citationRossi, G. P., Auchus, R. J., Brown, M., Lenders, J. W. M., Naruse, M., Plouin, P. F., Satoh, F., & Young, W. F. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02097 · Cited by 613
Self-citationSerum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033263 · Cited by 571
Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
Catena, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.33 · Cited by 565
Douma, S., Petidis, K., Doumas, M., Papaefthimiou, P., Triantafyllou, A., Kartali, N., Papadopoulos, N., Vogiatzis, K., & Zamboulis, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60834-x · Cited by 560
Can simple clinical measurements detect patient noncompliance?
Haynes, R. B., Taylor, D. W., Sackett, D. L., Gibson, E. S., Bernholz, C. D., & Mukherjee, J. (1980) · Hypertension · doi:10.1161/01.hyp.2.6.757 · Cited by 514
Kempers, M. J. E., Lenders, J. W. M., van Outheusden, L., van der Wilt, G. J., Schultze Kool, L. J., Hermus, A. R. M. M., & Deinum, J. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-5-200909010-00007 · Cited by 510
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
Mulatero, P., Monticone, S., Bertello, C., Viola, A., Tizzani, D., Iannaccone, A., Crudo, V., Burrello, J., Milan, A., Rabbia, F., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2805 · Cited by 415
Self-citationKäyser, S. C., Dekkers, T., Groenewoud, H. J., van der Wilt, G. J., Carel Bakx, J., van der Wel, M. C., Hermus, A. R., Lenders, J. W., & Deinum, J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1472 · Cited by 398
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
Freeman, M. W., Halvorsen, Y.-D., Marshall, W., Pater, M., Isaacsohn, J., Pearce, C., Murphy, B., Alp, N., Srivastava, A., Bhatt, D. L., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2213169 · Cited by 395
Rossi, G. P., Barisa, M., Allolio, B., Auchus, R. J., Amar, L., Cohen, D., Degenhart, C., Deinum, J., Fischer, E., Gordon, R., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2830 · Cited by 369
Self-citationAgarwal, R., Rossignol, P., Romero, A., Garza, D., Mayo, M. R., Warren, S., Ma, J., White, W. B., & Williams, B. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32135-x · Cited by 368
Williams, B., MacDonald, T. M., Morant, S. V., Webb, D. J., Sever, P., McInnes, G. T., Ford, I., Cruickshank, J. K., Caulfield, M. J., Padmanabhan, S., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30071-8 · Cited by 347
Mulatero, P., Monticone, S., Deinum, J., Amar, L., Prejbisz, A., Zennaro, M.-C., Beuschlein, F., Rossi, G. P., Nishikawa, T., Morganti, A., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002510 · Cited by 317
Self-citationSwiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302
Self-citationVaidya, A., Mulatero, P., Baudrand, R., & Adler, G. K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00139 · Cited by 299
Self-citationParthasarathy, H. K., Ménard, J., White, W. B., Young, W. F., Williams, G. H., Williams, B., Ruilope, L. M., McInnes, G. T., Connell, J. M., & MacDonald, T. M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283455ca5 · Cited by 281
Self-citationEfficacy and tolerance of spironolactone in essential hypertension
Jeunemaitre, X., Chatellier, G., Kreft-Jais, C., Charru, A., Devries, C., Plouin, P.-F., Corvol, P., & Menard, J. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91030-7 · Cited by 276
Dekkers, T., Prejbisz, A., Kool, L. J. S., Groenewoud, H. J. M. M., Velema, M., Spiering, W., Kołodziejczyk-Kruk, S., Arntz, M., Kądziela, J., Langenhuijsen, J. F., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30100-0 · Cited by 264
Adrenal Venous Sampling: Evaluation of the German Conn's Registry
Vonend, O., Ockenfels, N., Gao, X., Allolio, B., Lang, K., Mai, K., Quack, I., Saleh, A., Degenhart, C., Seufert, J., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168484 · Cited by 246
Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism
Hundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M., & Vaidya, A. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11568 · Cited by 245
Self-citationHundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M., & Vaidya, A. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2003 · Cited by 240
Self-citationPrimary Aldosteronism in Patients in China With Recently Detected Hypertension
Xu, Z., Yang, J., Hu, J., Song, Y., He, W., Luo, T., Cheng, Q., Ma, L., Luo, R., Fuller, P. J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.02.052 · Cited by 237
Self-citationThe Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study
Brown, J. M., Robinson-Cohen, C., Luque-Fernandez, M. A., Allison, M. A., Baudrand, R., Ix, J. H., Kestenbaum, B., de Boer, I. H., & Vaidya, A. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0882 · Cited by 221
Self-citationNewton-Cheh, C., Guo, C.-Y., Gona, P., Larson, M. G., Benjamin, E. J., Wang, T. J., Kathiresan, S., O’Donnell, C. J., Musone, S. L., Camargo, A. L., et al. (2007) · Hypertension · doi:10.1161/01.hyp.0000258554.87444.91 · Cited by 218
Naruse, M., Katabami, T., Shibata, H., Sone, M., Takahashi, K., Tanabe, A., Izawa, S., Ichijo, T., Otsuki, M., Omura, M., et al. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0508 · Cited by 217
Young, W. F., & Stanson, A. W. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03450.x · Cited by 215
Self-citationLim, V., Guo, Q., Grant, C. S., Thompson, G. B., Richards, M. L., Farley, D. R., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4146 · Cited by 208
Self-citationPrimary aldosteronism — a multidimensional syndrome
Turcu, A. F., Yang, J., & Vaidya, A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00730-2 · Cited by 189
Self-citationGuidelines for primary aldosteronism: uptake by primary care physicians in Europe
Mulatero, P., Monticone, S., Burrello, J., Veglio, F., Williams, T. A., & Funder, J. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001088 · Cited by 185
Self-citationWu, X., Senanayake, R., Goodchild, E., Bashari, W. A., Salsbury, J., Cabrera, C., Argentesi, G., O’Toole, S. M., Matson, M. B., Koo, B., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02114-5 · Cited by 178
Brown, J. J., Davies, D. L., Ferriss, J. B., Fraser, R., Haywood, E., Lever, A. F., & Robertson, J. I. S. (1972) · BMJ · doi:10.1136/bmj.2.5816.729 · Cited by 177
Renal damage in primary aldosteronism: a systematic review and meta-analysis
Monticone, S., Sconfienza, E., D’Ascenzo, F., Buffolo, F., Satoh, F., Sechi, L. A., Veglio, F., & Mulatero, P. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002216 · Cited by 173
Self-citationCohen, J. B., Cohen, D. L., Herman, D. S., Leppert, J. T., Byrd, J. B., & Bhalla, V. (2021) · Annals of Internal Medicine · doi:10.7326/m20-4873 · Cited by 173
Carey, R. M. (1972) · Archives of Internal Medicine · doi:10.1001/archinte.130.6.849 · Cited by 173
Pathogenesis and treatment of primary aldosteronism
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0382-4 · Cited by 170
Self-citationHeinze, B., Fuss, C. T., Mulatero, P., Beuschlein, F., Reincke, M., Mustafa, M., Schirbel, A., Deutschbein, T., Williams, T. A., Rhayem, Y., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.09975 · Cited by 169
Self-citationSukor, N., Gordon, R. D., Ku, Y. K., Jones, M., & Stowasser, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2803 · Cited by 165
Self-citationBurrello, J., Monticone, S., Losano, I., Cavaglià, G., Buffolo, F., Tetti, M., Covella, M., Rabbia, F., Veglio, F., Pasini, B., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14063 · Cited by 162
Self-citationJing, Y., Hu, J., Luo, R., Mao, Y. J., Luo, Z., Zhang, M., Yang, J., Song, Y., Feng, Z., Wang, Z., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m22-1619 · Cited by 157
Self-citationMulatero, P., Sechi, L. A., Williams, T. A., Lenders, J. W. M., Reincke, M., Satoh, F., Januszewicz, A., Naruse, M., Doumas, M. N., Veglio, F., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002520 · Cited by 147
Self-citationVelema, M. S., Dekkers, T., Hermus, A. R., Timmers, H. J. L. M., Lenders, J. W. M., Groenewoud, H., Kool, L. J. S., Langenhuijsen, J. F., Prejbisz, A., van der Wilt, G. J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01442 · Cited by 142
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism
Karagiannis, A. I., Τζιόμαλος, Κ., Papageorgiou, T., Kakafika, A. I., Pagourelias, E. D., Anagnostis, P. G., Athyros, V. G., & Mikhailidis, D. P. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.4.509 · Cited by 137
Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism
Späth, M. R., Korovkin, S., Antke, C., Anlauf, M., & Willenberg, H. S. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1070 · Cited by 137
Fogari, R., Preti, P. S., Zoppi, A., Rinaldi, A., Fogari, E., & Mugellini, A. (2007) · Hypertension Research · doi:10.1291/hypres.30.111 · Cited by 134
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism
Williams, T. A., Burrello, J., Sechi, L. A., Fardella, C., Matrozova, J., Adolf, C., Baudrand, R. F., Bernardi, S., Beuschlein, F., Catena, C., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11382 · Cited by 134
Self-citationConfirmatory Tests for the Diagnosis of Primary Aldosteronism
Song, Y., Yang, S., He, W., Hu, J., Cheng, Q., Wang, Y., Luo, T., Ma, L., Zhen, Q., Zhang, S., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10197 · Cited by 132
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization
Rossitto, G., Amar, L., Azizi, M., Riester, A., Reincke, M., Degenhart, C., Widimsky, J., Jr., Naruse, M., Deinum, J., SchultzeKool, L. J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz017 · Cited by 132
Self-citationYozamp, N. S., Hundemer, G. L., Moussa, M., Underhill, J., Fudim, T., Sacks, B. A., & Vaidya, A. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.16429 · Cited by 129
Self-citationEisenhofer, G., Durán, C., Cannistraci, C. V., Peitzsch, M., Williams, T. A., Riester, A., Burrello, J., Buffolo, F., Prejbisz, A., Beuschlein, F., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.16209 · Cited by 128
Self-citationSeated Saline Suppression Testing For The Diagnosis Of Primary Aldosteronism: A Preliminary Study
Ahmed, A. H., Cowley, D., Wolley, M. J., Gordon, R. D., Xu, S., Taylor, P. J., & Stowasser, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1153 · Cited by 122
Self-citationStowasser, M., Ahmed, A. H., Cowley, D., Wolley, M. J., Guo, Z., McWhinney, B. C., Ungerer, J. P. J., & Gordon, R. D. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01394 · Cited by 121
Self-citationHundemer, G. L., Imsirovic, H., Vaidya, A., Yozamp, N., Goupil, R., Madore, F., Agharazii, M., Knoll, G., & Sood, M. M. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.18118 · Cited by 121
Self-citationParasiliti‐Caprino, M., Lopez, C., Prencipe, N., Lucatello, B. G., Settanni, F., Giraudo, G., Rossato, D., Mengozzi, G., Ghigo, E., Benso, A. S., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002441 · Cited by 120
Multimarker Approach to Evaluate Correlates of Vascular Stiffness
Lieb, W., Larson, M. G., Benjamin, E. J., Yin, X., Tofler, G. H., Selhub, J., Jacques, P. F., Wang, T. J., Vita, J. A., Levy, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.816108 · Cited by 119
Iwakura, Y., Morimoto, R., Kudo, M., Ono, Y., Takase, K., Seiji, K., Arai, Y., Nakamura, Y., Sasano, H., Ito, S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2180 · Cited by 116
Ahmed, A. H., Gordon, R. D., Sukor, N., Pimenta, E., & Stowasser, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0138 · Cited by 115
Self-citationEffects of eplerenone versus losartan in patients with low-renin hypertension
Weinberger, M. H., White, W. B., Ruilope, L. M., MacDonald, T. M., Davidson, R. C., Roniker, B., Patrick, J. L., & Krause, S. L. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.12.005 · Cited by 115
Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion
Gerards, J., Heinrich, D. A., Adolf, C., Meisinger, C., Rathmann, W., Sturm, L., Nirschl, N., Bidlingmaier, M., Beuschlein, F., Thorand, B., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00299 · Cited by 112
Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study
Hundemer, G. L., Agharazii, M., Madore, F., Vaidya, A., Brown, J. M., Leung, A. A. C., Kline, G. A., Larose, É., Piché, M., Crean, A. M., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.066389 · Cited by 112
Self-citationReel, P. S., Reel, S., van Kralingen, J. C., Langton, K., Lang, K., Erlic, Z., Larsen, C. K., Amar, L., Pamporaki, C., Mulatero, P., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104276 · Cited by 111
Self-citationHyperaldosteronism as a Common Cause of Resistant Hypertension
Calhoun, D. A. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-042711-135929 · Cited by 108
A Multi-Marker Approach to Predict Incident CKD and Microalbuminuria
Fox, C. S., Gona, P. N., Larson, M. G., Selhub, J., Tofler, G. H., Hwang, S., Meigs, J. B., Levy, D. A., Wang, T. J., Jacques, P. F., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010085 · Cited by 108
Detecting primary aldosteronism in Australian primary care: a prospective study
Libianto, R., Russell, G. M., Stowasser, M., Gwini, S. M., Nuttall, P., Shen, J., Young, M. J., Fuller, P. J., & Yang, J. (2022) · The Medical Journal of Australia · doi:10.5694/mja2.51438 · Cited by 107
Self-citationHood, S. J., Taylor, K., Ashby, M. J., & Mj, B. (2007) · Circulation · doi:10.1161/circulationaha.107.690396 · Cited by 105
Monticone, S., Satoh, F., Giacchetti, G., Viola, A., Morimoto, R., Kudo, M., Iwakura, Y., Ono, Y., Turchi, F., Paci, E., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.189548 · Cited by 105
Self-citationAccuracy of laboratory tests for the diagnosis of Cushing syndrome
Galm, B. P., Qiao, N., Klibanski, A., Biller, B. M. K., & Tritos, N. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa105 · Cited by 100
Bertherat, J. Y., Bourdeau, I., Bouys, L., Chasseloup, F., Kamenický, P., & Lacroix, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac034 · Cited by 99
Resistant hypertension and target organ damage
Muiesan, M. L., Salvetti, M., Rizzoni, D., Paini, A., Agabiti-Rosei, C., Aggiusti, C., & Rosei, E. A. (2013) · Hypertension Research · doi:10.1038/hr.2013.30 · Cited by 98
Hill, M. A., Jaisser, F., & Sowers, J. R. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa326 · Cited by 97
Biomarkers to Guide Medical Therapy in Primary Aldosteronism
Hundemer, G. L., Leung, A. A. C., Kline, G. A., Brown, J. M., Turcu, A. F., & Vaidya, A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad024 · Cited by 97
Self-citationSeccia, T. M., Letizia, C., Muiesan, M. L., Lerco, S., Cesari, M., Bisogni, V., Petramala, L., Maiolino, G., Volpin, R., & Rossi, G. P. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002250 · Cited by 96
Plasma Metanephrine for Assessing the Selectivity of Adrenal Venous Sampling
Dekkers, T., Deinum, J., SchultzeKool, L. J., Blondin, D., Vonend, O., Hermus, A. R. R., Peitzsch, M., Rump, L. C., Antoch, G., Sweep, F. C. G. J., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01601 · Cited by 94
Comparison of Sequential versus Simultaneous Methods of Adrenal Venous Sampling
Carr, C. E., Cope, C., Cohen, D. L., Fraker, D. L., & Trerotola, S. O. (2004) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000134495.26900.6a · Cited by 91
Primary aldosteronism: a common cause of resistant hypertension
Kline, G. A., Prebtani, A. P. H., Leung, A. A. C., & Schiffrin, E. L. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.161486 · Cited by 90
Self-citationOutcomes of a Specialized Clinic on Rates of Investigation and Treatment of Primary Aldosteronism
Liu, Y.-Y., King, J. A., Kline, G. A., Padwal, R. S., Pasieka, J. L., Chen, G., So, B., Harvey, A. M., Chin, A., & Leung, A. A. C. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2021.0254 · Cited by 90
Self-citationThe Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy
Eisenhofer, G., Kurlbaum, M., Peitzsch, M., Constantinescu, G. A., Remde, H., Schulze, M., Kaden, D., Müller, L., Fuß, C. T., Kunz, S. L., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab924 · Cited by 89
Self-citationLeung, A. A., Symonds, C. J., Hundemer, G. L., Ronksley, P. E., Lorenzetti, D. L., Pasieka, J. L., Harvey, A., & Kline, G. A. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19377 · Cited by 89
Self-citationComparison of eplerenone and spironolactone for the treatment of primary aldosteronism
Karashima, S., Yoneda, T., Kometani, M., Ohe, M., Mori, S., Sawamura, T., Furukawa, K., Seta, T., Yamagishi, M., & Takeda, Y. (2015) · Hypertension Research · doi:10.1038/hr.2015.129 · Cited by 88
Risk of Fracture in Primary Aldosteronism: A Population-Based Cohort Study
Wu, V., Chang, C., Wang, C.-Y., Lin, Y., Kao, T., Lin, P., Chu, T., Chang, Y.-S., Chen, L., Wu, K., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3033 · Cited by 88
Epithelial Sodium Channel in Aldosterone-Induced Endothelium Stiffness and Aortic Dysfunction
Jia, G., Habibi, J., Aroor, A. R., Hill, M. A., Yang, Y., Whaley‐Connell, A. T., Jaisser, F., & Sowers, J. R. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11339 · Cited by 88
Thuzar, M., Young, K., Ahmed, A. H., Ward, G., Wolley, M. J., Guo, Z., Gordon, R. D., McWhinney, B. C., Ungerer, J. P. J., & Stowasser, M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz150 · Cited by 86
Self-citationFourkiotis, V., Vonend, O., Diederich, S., Fischer, E., Lang, K., Endres, S., Beuschlein, F., Willenberg, H. S., Rump, L. C., Allolio, B., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0631 · Cited by 84
Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy
Adolf, C., Köhler, A., Franke, A., Lang, K., Riester, A., Löw, A., Heinrich, D. A., Bidlingmaier, M., Treitl, M., Ladurner, R., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00617 · Cited by 84
Screening for primary aldosteronism on and off interfering medications
Li, X., Liang, J., Hu, J., Ma, L., Yang, J., Zhang, A., Jing, Y., Song, Y., Yang, Y., Feng, Z., et al. (2023) · Endocrine · doi:10.1007/s12020-023-03520-6 · Cited by 82
Self-citationDietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism
Baudrand, R. F., Guarda, F. J., Torrey, J., Williams, G. H., & Vaidya, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1963 · Cited by 80
Self-citationIs Primary Aldosteronism Still Largely Unrecognized?
Buffolo, F., Monticone, S., Burrello, J., Tetti, M., Veglio, F., Williams, T. A., & Mulatero, P. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-119755 · Cited by 77
Self-citationUmakoshi, H., Ogasawara, T., Takeda, Y., Kurihara, I., Itoh, H., Katabami, T., Ichijo, T., Wada, N., Shibayama, Y., Yoshimoto, T., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13582 · Cited by 77
The Value of Targeting CXCR4 With 68Ga-Pentixafor PET/CT for Subtyping Primary Aldosteronism
Zheng, Y., Long, T., Peng, N., Zhen, M., Ye, Q., Zhang, Z., He, Y., Zhi, C., Gan, Y., Luo, M., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad421 · Cited by 76
Nakajima, Y., Yamada, M., Taguchi, R., Satoh, T., Hashimoto, K., Ozawa, A., Shibusawa, N., Okada, S., Monden, T., & Mori, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2743 · Cited by 74
Guo, Z., Poglitsch, M., McWhinney, B. C., Ungerer, J. P. J., Ahmed, A. H., Gordon, R. D., Wolley, M. J., & Stowasser, M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01041 · Cited by 72
Self-citationThe Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study
Parksook, W. W., Brown, J. M., Omata, K., Tezuka, Y., Ono, Y., Satoh, F., Tsai, L. C., Niebuhr, Y., Milks, J., Moore, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae145 · Cited by 72
Self-citationWu, V.-C., Wang, S.-M., Huang, K.-H., Tsai, Y. C., Chan, C.-K., Yang, S.-Y., Lin, L.-Y., Chang, C., Lu, C.-C., Lin, Y.-H., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0836 · Cited by 71
Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure
Faridi, K. F., Dayoub, E. J., Ross, J. S., Dhruva, S. S., Ahmad, T., & Desai, N. R. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.04.031 · Cited by 69
Meneton, P., Galan, P., Bertrais, S., Heudes, D., Herçberg, S., & Ménard, J. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.27 · Cited by 68
Brown, J. M., Wijkman, M. O., Claggett, B. L., Shah, A. M., Ballantyne, C. M., Coresh, J., Grams, M. E., Wang, Z., Yu, B., Boerwinkle, E., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19134 · Cited by 68
Self-citationLubitz, C. C., Economopoulos, K. P., Sy, S., Johanson, C., Kunzel, H. E., Reincke, M., Gazelle, G. S., Weinstein, M. C., & Gaziano, T. A. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002002 · Cited by 67
Nanba, A. T., Wannachalee, T., Shields, J. J., Byrd, J. B., Rainey, W. E., Auchus, R. J., & Turcu, A. F. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01299 · Cited by 63
Oxlund, C. S., Buhl, K. B., Jacobsen, I. A., Hansen, M. R., Gram, J., Henriksen, J. E., Schousboe, K., Tarnow, L., & Jensen, B. L. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.09.019 · Cited by 62
Concurrent primary aldosteronism and subclinical cortisol hypersecretion
Fallo, F., Bertello, C., Tizzani, D., Fassina, A., Boulkroun, S., Sonino, N., Monticone, S., Viola, A., Veglio, F., & Mulatero, P. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834937f3 · Cited by 61
Self-citationKosiborod, M., Cherney, D. Z. I., Desai, A. S., Testani, J. M., Verma, S., Chinnakondepalli, K., Dolling, D. I., Patel, S., Dahl, M., Eudicone, J. M., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.11.014 · Cited by 61
Adrenal disorders in pregnancy
Monticone, S., Auchus, R. J., & Rainey, W. E. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.155 · Cited by 58
Hu, J., Shen, H., Huo, P., Yang, J., Fuller, P. J., Wang, K., Yang, Y., Ma, L., Cheng, Q., Gong, L., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.023082 · Cited by 56
Self-citationAdrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study
Williams, T. A., Gong, S., Tsurutani, Y., Tezuka, Y., Thuzar, M., Burrello, J., Wu, V., Yamazaki, Y., Mulatero, P., Sasano, H., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00253-4 · Cited by 55
Self-citationAdrenal Venous Sampling for Assessment of Autonomous Cortisol Secretion
Ueland, G. Å., Methlie, P., Jøssang, D. E., Sagen, J. V., Viste, K., Thordarson, H. B., Heie, A., Grytaas, M. A., Løvås, K., Biermann, M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01198 · Cited by 54
Sander, K., Gendron, T., Cybulska, K. A., Sirindil, F., Zhou, J., Kalber, T. L., Lythgoe, M. F., Kurzawinski, T. R., Mj, B., Williams, B., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00539 · Cited by 54
Community Care in England: Reducing Socioeconomic Inequalities in Heart Failure
Hawkins, N. M., Scholes, S., Bajekal, M., Love, H., O'Flaherty, M., Raine, R., & Capewell, S. (2012) · Circulation · doi:10.1161/circulationaha.111.088047 · Cited by 52
Morera, J., & Reznik, Y. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0704 · Cited by 52
Tang, L., Li, X., Wang, B., Ma, X., Li, H., Gao, Y., Gu, L., Nie, W., & Zhang, X. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4920841 · Cited by 51
Cornu, E., Steichen, O., Nogueira‐Silva, L., Küpers, E. M., Pagny, J.-Y., Grataloup, C., Baron, S., Zinzindohoué, F., Plouin, P., & Amar, L. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07214 · Cited by 50
O’Toole, S. M., Sze, W.-C., Chung, T., Akker, S. A., Druce, M. R., Waterhouse, M., Pitkin, S. L., Dawnay, A., Sahdev, A., Matson, M. B., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa519 · Cited by 49
Douglas, J. G. (1974) · JAMA · doi:10.1001/jama.227.5.518 · Cited by 49
Shah, S. S., Zhang, J., Gwini, S. M., Young, M. J., Fuller, P. J., & Yang, J. (2024) · Journal of Human Hypertension · doi:10.1038/s41371-023-00891-1 · Cited by 49
Self-citationMartínez‐Aguayo, A., Marlene Aglony, I., Campino, C., García, H., Bancalari, R. E., Bolte, L., Avalos, C., Loureiro, C., Carvajal, C. A., Ávila, A., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.155135 · Cited by 48
Hu, Y., Zhang, J., Liu, W., & Su, X. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz293 · Cited by 46
Brown, J. M., Auchus, R. J., Honzel, B., Luther, J. M., Yozamp, N. S., & Vaidya, A. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac049 · Cited by 46
Self-citationPrimary aldosteronism in pregnancy
Forestiero, V., Sconfienza, E., Mulatero, P., & Monticone, S. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09729-6 · Cited by 46
Self-citationGoupil, R., Wolley, M. J., Ahmed, A. H., Gordon, R. D., & Stowasser, M. (2015) · Clinical Endocrinology · doi:10.1111/cen.12750 · Cited by 45
Self-citationMulatero, P., Scholl, U. I., Fardella, C., Charmandari, E., Januszewicz, A., Reincke, M., Gómez-Sánchez, C. E., Stowasser, M., & Dekkers, O. M. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae041 · Cited by 45
Self-citationSubtyping of Primary Aldosteronism by Adrenal Venous Sampling
Rossi, G. P., Battistel, M., Seccia, T. M., Rossi, F. B., & Rossitto, G. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf007 · Cited by 44
Murase, K., Nagaishi, R., Takenoshita, H., Nomiyama, T., Akehi, Y., & Yanase, T. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0060 · Cited by 43
Alonso‐Coello, P., Oxman, A. D., Moberg, J., Brignardello‐Petersen, R., Akl, E. A., Davoli, M., Treweek, S. P., Mustafa, R. A., Vandvik, P. O., Meerpohl, J. J., et al. (2017) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2017.03.008 · Cited by 43
Hu, J., Zhou, Q., Sun, Y., Feng, Z., Yang, J., He, W., Song, Y., Wang, Y., Chen, X., Shen, H., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.071452 · Cited by 43
Self-citationDeLozier, O. M., Dream, S. Y., Findling, J. W., Carroll, T. B., Evans, D. B., & Wang, T. S. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab698 · Cited by 42
Kline, G. A., Pasieka, J. L., Harvey, A. M., So, B., & Dias, V. C. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12342 · Cited by 41
Self-citationIs it time to screen all patients with hypertension for primary aldosteronism?
Yang, J., Fuller, P. J., & Stowasser, M. (2018) · The Medical Journal of Australia · doi:10.5694/mja17.00783 · Cited by 41
Self-citationWolley, M. J., Thuzar, M., & Stowasser, M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101400 · Cited by 41
Self-citationMaciel, A. A. W., Freitas, T. C., Fagundes, G. F. C., Petenuci, J., Vilela, L. A. P., Brito, L. P., Goldbaum, T. S., Zerbini, M. C. N., Ledesma, F. L., Tanno, F. Y., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac679 · Cited by 41
Confirmatory Testing for Primary Aldosteronism: A Study of Diagnostic Test Accuracy
Leung, A. A. C., Padwal, R. S., Hundemer, G. L., Venos, E., Campbell, D. J. T., Holmes, D. T., Orton, D. J., So, B., Przybojewski, S. J., Caughlin, C. E., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-03153 · Cited by 41
Self-citationTakeda, Y., Umakoshi, H., Takeda, Y., Yoneda, T., Kurihara, I., Katabami, T., Ichijo, T., Wada, N., Yoshimoto, T., Ogawa, Y., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001964 · Cited by 39
Rossi, G. P., Rossitto, G., Amar, L., Azizi, M., Riester, A., Reincke, M., Degenhart, C., Widimsky, J., Jr., Naruse, M., Deinum, J., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa108 · Cited by 39
Self-citationAdrenal vein sampling: Substantial need for technical improvement at regional referral centres
Elliott, P., & Holmes, D. T. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.04.004 · Cited by 38
The management of aldosterone-producing adrenal adenomas—does adrenalectomy increase costs?
Reimel, B., Zanocco, K. A., Russo, M. J., Zarnegar, R., Clark, O. H., Allendorf, J., Chabot, J. A., Duh, Q., Lee, J. A., & Sturgeon, C. (2010) · Surgery · doi:10.1016/j.surg.2010.09.012 · Cited by 37
Tsai, C., Liao, C., Wu, X.-M., Chen, Z., Pan, C., Chang, Y., Lee, B., Shun, C., Wen, W.-F., Chou, C., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1157 · Cited by 36
Buffolo, F., Pieroni, J., Ponzetto, F., Forestiero, V., Rossato, D., Fonio, P., Nonnato, A., Settanni, F., Mulatero, P., Mengozzi, G., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad179 · Cited by 35
Self-citationBuffolo, F., Pecori, A., Reincke, M., Outland, M., Veglio, F., Schwarzlmueller, P., Bidlingmaier, M., Kunz, S. L., Stremmel, C., Mengozzi, G., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21983 · Cited by 35
Self-citationGoodchild, E., Wu, X., Senanayake, R., MacFarlane, J., Argentesi, G., Laycock, K., Bashari, W. A., Cabrera, C., O’Toole, S. M., Salsbury, J., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-00761 · Cited by 35
Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk
Katabami, T., Matsuba, R., Kobayashi, H. H., Nakagawa, T., Kurihara, I., Ichijo, T., Tsuiki, M., Wada, N., Ogawa, Y., Sone, M., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1131 · Cited by 34
Diagnostic Delay and Disease Burden in Primary Aldosteronism: An International Patient Survey
Ananda, R. A., Gwini, S. M., Long, K. M., Lai, J. H., Chen, G., Russell, G. M., Stowasser, M., Fuller, P. J., & Yang, J. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21965 · Cited by 34
Self-citationAdrenal Venous Sampling in Young Patients with Primary Aldosteronism. Extravagance or Irreplaceable?
Gkaniatsa, E., Sakinis, A., Palmér, M., Muth, A., Trimpou, P., & Ragnarsson, Ó. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab047 · Cited by 33
Cost-Effectiveness Analysis of the Diagnosis and Treatment of Primary Aldosteronism in Japan
Sato, M., Morimoto, R., Seiji, K., Iwakura, Y., Ono, Y., Kudo, M., Satoh, F., Ito, S., Ishibashi, T., & Takase, K. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1559645 · Cited by 32
Lee, S. H., Kim, J. W., Yoon, H., Koh, J.-M., Shin, C. S., Kim, J. H., & Kim, J. H. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2020.901 · Cited by 32
Ariens, J., Horvath, A. R., Yang, J., & Choy, K. W. (2022) · Endocrine · doi:10.1007/s12020-022-03084-x · Cited by 32
Self-citationCeolotto, G., Antonelli, G., Caroccia, B., Battistel, M., Barbiero, G., Plebani, M., & Rossi, G. P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204755 · Cited by 31
Puar, T. H. K., Cheong, C. K., Foo, R., Saffari, S. E., Tu, T. M., Chee, M. R., Zhang, M., Ng, K. S., Wong, K. M., Wong, A. S. Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.916744 · Cited by 31
Heinrich, D. A., Quinkler, M. O., Adolf, C., Handgriff, L., Müller, L., Schneider, H., Sturm, L., Kunzel, H. E., Seidensticker, M., Deniz, S., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-0541 · Cited by 31
Katsuragawa, S., Goto, A., Shinoda, S., Inoue, K., Nakai, K., Saito, J., Nishikawa, T., & Tsurutani, Y. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21096 · Cited by 31
Exclusion Tests in Unilateral Primary Aldosteronism (ExcluPA) Study
Zhu, R., Shagjaa, T., Rossitto, G., Caroccia, B., Seccia, T. M., Gregori, D., & Rossi, G. P. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac654 · Cited by 30
Schneider, H., Sarkis, A., Sturm, L., Britz, V., Lechner, A., Potzel, A. L., Müller, L., Heinrich, D. A., Kunzel, H. E., Nowotny, H. F., et al. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13618 · Cited by 30
Urine steroid metabolomics as a diagnostic tool in primary aldosteronism
Prete, A., Lang, K., Pavlov, D., Rhayem, Y., Sitch, A. J., Franke, A. S., Gilligan, L. C., Shackleton, C. H. L., Hahner, S., Quinkler, M. O., et al. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106445 · Cited by 30
Frankenstein, L., Seide, S. E., Täger, T., Jensen, K., Fröhlich, H., Clark, A. L., Seiz, M., Katus, H. A., Nee, P., Uhlmann, L., et al. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09832-y · Cited by 29
Basal contralateral aldosterone suppression is rare in lateralized primary aldosteronism
Desrochers, M.-J., St‐Jean, M., Ghorayeb, N. E., Bourdeau, I., So, B., Thérasse, É., Kline, G. A., & Lacroix, A. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0254 · Cited by 29
Self-citationNainani, A., Yang, J., Peters, S., & Russell, G. M. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061671 · Cited by 29
Self-citationFarah, M. H., Hegazi, M., Firwana, M., Abusalih, M. E., Saadi, S. M., Al-Kordi, M., Elsheikh, A. M., Wang, Z., Hassett, L. C., Bancos, I., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf290 · Cited by 29
Self-citationInoue, K., Kitamoto, T., Tsurutani, Y., Saito, J., Omura, M., & Nishikawa, T. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.645488 · Cited by 28
Spironolactone and amiloride in hypertensive patients with and without aldosterone excess
Hoefnagels, W. H. L., Drayer, J. I. M., SMALS, A. G. H., et al. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.42 · Cited by 27
Murad, M. H., Liem, R. I., Lang, E., Akl, E. A., Meerpohl, J. J., DeBaun, M. R., Tisdale, J. F., Brandow, A. M., Lanzkron, S., Chou, S. T., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000931 · Cited by 27
Self-citationThe relevance of cortisol co-secretion from aldosterone-producing adenomas
Bhatt, P. S., Sam, A. H., Meeran, K. M., & Salem, V. (2019) · HORMONES · doi:10.1007/s42000-019-00114-8 · Cited by 26
Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials
Trinchieri, A., Perletti, G., Magri, V., Stamatiou, K. N., Trinchieri, M., & Montanari, E. (2021) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2021.4.489 · Cited by 26
Saiki, A., Otsuki, M., Tamada, D., Kitamura, T., Mukai, K., Yamamoto, K. I., & Shimomura, I. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab174 · Cited by 26
Standardized wording to improve efficiency and clarity of GRADE EtD frameworks in health guidelines
Piggott, T., Baldeh, T., Dietl, B., Wiercioch, W., Nieuwlaat, R., Santesso, N. A., Alonso‐Coello, P., & Schünemann, H. J. (2022) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2022.01.004 · Cited by 26
Pan, C., Liao, C., Tsai, C., Chen, Z., Chen, L., Hung, C., Liu, Y., Lin, P., Chang, C., Chang, Y., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013699 · Cited by 25
Quality of life in primary aldosteronism: A prospective observational study
Buffolo, F., Cavaglià, G., Burrello, J., Amongero, M., Tetti, M., Pecori, A., Sconfienza, E., Veglio, F., Mulatero, P., & Monticone, S. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13419 · Cited by 25
Self-citationThiesmeyer, J. W., Ullmann, T. M., Stamatiou, A. T., Limberg, J. N., Stefanova, D. I., Beninato, T. M., Finnerty, B. M., Vignaud, T., Leclerc, J., Fahey, T. J., et al. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.5011 · Cited by 25
Beuschlein, F., Reincke, M., & Arlt, W. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001550 · Cited by 23
Tan, Y. K., Kwan, Y. H., Teo, D. C. L., Velema, M. S., Deinum, J., Tan, P. T., Zhang, M., Khoo, J. J. C., Loh, W. J., Gani, L. U., et al. (2021) · Endocrine Connections · doi:10.1530/ec-21-0125 · Cited by 22
Yamashita, T. S., Shariq, O. A., Foster, T. R., Lyden, M. L., Dy, B. M., Young, W. F., Bancos, I., & McKenzie, T. J. (2022) · World Journal of Surgery · doi:10.1007/s00268-022-06780-x · Cited by 22
Self-citationWoode, M. E., Wong, K., Reid, C. M., Stowasser, M., Russell, G. M., Gwini, S. M., Young, M. J., Fuller, P. J., Yang, J., & Chen, G. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003513 · Cited by 22
Self-citationZhang, X.-G., Song, Y., Jing, Y., Hu, J., Shen, H., Zhang, A., He, W., Feng, Z., Yang, Y., Pang, H., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae747 · Cited by 22
Ananda, R. A., Gwini, S. M., Beilin, L. J., Schlaich, M. P., Stowasser, M., Young, M. J., Adler, B. D., Fuller, P. J., Mori, T. A., & Yang, J. (2024) · Circulation · doi:10.1161/circulationaha.124.070039 · Cited by 21
Self-citationLi, X., Goswami, R., Yang, S., & Li, Q. (2016) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320316657450 · Cited by 19
Yatabe, M., Bokuda, K., Yamashita, K., Morimoto, S., Yatabe, J., Seki, Y., Watanabe, D., Morita, S., Sakai, S., & Ichihara, A. (2020) · Hypertension Research · doi:10.1038/s41440-020-0445-x · Cited by 19
Cost‐effectiveness analysis of screening for primary aldosteronism in China
Li, N., Huang, J., Zheng, B., Cai, H., Liu, M., & Liu, L. (2021) · Clinical Endocrinology · doi:10.1111/cen.14478 · Cited by 19
Tolerability and Efficacy of Long-Term Medical Therapy in Primary Aldosteronism
Tang, F., Loh, L. M., Foo, R., Loh, W. J., Lim, D. S. T., Zhang, M., Tan, P. T., Swee, D. S., Khoo, J. J. C., Tay, D., et al. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab144 · Cited by 19
Kristensen, M., Fenton, R. A., & Poulsen, S. B. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.800055 · Cited by 19
ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism
Tsai, C., Brown, J. M., Salle, S. P., Newman, A. J., Wu, V., Lin, Y., & Vaidya, A. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.24711 · Cited by 19
Self-citationKishino, M., Yoshimoto, T., Nakadate, M., et al. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0433 · Cited by 18
Ma, D., Liu, X., Zeng, L., Yuan, P., Liu, Z., Xie, J., Yuan, G., Wang, S., Yu, X., Yang, Y., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002634 · Cited by 17
Farinelli, D. G., Oliveira, K. C., Hayashi, L. F., & Kater, C. E. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.09.007 · Cited by 17
Metadata
- Authors
- Adler, G. K., Stowasser, M., Correa, R. R., Khan, N., Kline, G., McGowan, M. J., Mulatero, P., Murad, M. H., Touyz, R. M., Vaidya, A., Williams, T. A., Yang, J., Young, W. F., Zennaro, M.-C., & Brito, J. P.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2025-07-14
- Volume
- 110
- Issue
- 9
- Pages
- 2453-2495
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W4412473622
- Cited by
- 355
- References
- 222
- FWCI
- 211.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.